Position/Title: Dengue Technical Advisor

Length of position: Three months, with possible extension

Estimated renumeration: Estimated 200-250 million IDR for project duration

Reports to: CHAI Indonesia Associate Program Director

Background

The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.

CHAI was founded in 2002 in response to the HIV/AIDS epidemic with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.

CHAI began supporting Indonesia’s Ministry of Health (MOH) in 2006 to improve HIV diagnosis and treatment in the Papua and West Papua regions. We partnered with the government to implement its Rapidly Expanding Access to Care for HIV/AIDS (REACH) program, expanding access to quality HIV care, treatment, and support services for millions of Indonesians. We also trained thousands of health workers and helped establish nine Centers of Excellence as regional referral centers for complicated cases. In the last five years, we have expanded our work to strengthen priority health programs including maternal and child health services in primary care working with private sector, reduce the burden of hepatitis, and improve access to routine vaccinations through facilitating the nationwide scale-up of pneumococcal conjugate, rotavirus and human papillomavirus vaccines. We also partnered with the government to improve access to the early detection and treatment of pediatric cancer, assistive technology for disabled children, and oxygen to treat COVID-19 and other respiratory conditions.

Program

Dengue fever is a major public health problem In Indonesia, with 100,000 cases reported on average in recent years and over 250,000 cases including nearly 1500 deaths during the outbreak in 2024. The disease is endemic across all provinces, with transmission occurring year-round and peaking during the rainy season from October to April.

Climate change has exacerbated the spread of disease by altering rainfall patterns, increasing temperatures, and extending the breeding season of Aedes aegypti mosquitos as the main dengue vector. Wolbachia—a naturally occurring bacterium found in many insects—offers a promising, sustainable strategy to reduce dengue transmission by blocking viral replication when introduced into mosquitoes. Through successive releases of mosquitos infected with Wolbachia in a given area, the bacterium spreads through offspring and Wolbachia-carrying mosquitos become the dominant population, thus blocking transmission.

Yogyakarta, Indonesia was the site of a pivotal randomized controlled Wolbachia release trial from 2016-2020 which demonstrated a 77% reduction in dengue incidence and 86% reduction in hospitalizations. Due to the success of the pilot, Wolbachia has since been endorsed by Indonesia’s Ministry of Health and is being scaled up across five additional cities under ministerial decree. The goal is to eventually expand to 20 and eventually 100 cities, but the scale-up will require a clear vision, clarity on supplier and implementation models, and engagement with key stakeholders across the dengue landscape (e.g., government, policymakers, research institutions, local communities, funders/donors).

Description

CHAI is seeking a Technical Advisor to lead the assessment of Indonesia’s theory of change and vision for scaling Wolbachia-based interventions to control dengue fever, including an in-depth Wolbachia supplier mapping and analysis. The Advisor will help CHAI map current dengue stakeholders and engagement within Indonesia, conduct comparisons of supplier options (including differences in technology, pricing, implementation models, and other relevant factors), evaluate learnings and challenges from the current 5-city program that may inform scale-up decisions, and develop a decision roadmap to help guide the MOH in next steps.  The Advisor will join a diverse and technically strong team of entrepreneurial problem-solvers.

The position requires a high level of direct coordination with multiple stakeholders within the government, partners, and CHAI’s country, regional, and global technical teams. S/he may represent CHAI in high-level meetings with government partners. The Advisor must be a highly motivated, entrepreneurial individual with outstanding people and program management, problem-solving, analytical, and communication skills. The position may require travel to certain regions, such as Semarang (Central Java), West Jakarta, Bandung (West Java), Kupang (East Nusa Tenggara), and/or Bontang (East Kalimantan).

Main Responsibilities

• Lead the completion of an Indonesia Dengue Landscape and Supplier Assessment, including but not limited to:
  • Stakeholder governance and influencer mapping, e.g.,
    • Lead engagement, coordination, and strategic analysis of key stakeholders across government, research/academia, donors, and more
  • Analysis of key learnings and challenges in current 5-city scale-up, e.g.,
    • Map production and supply chain processes, calculate cost impacts from operational or budget constraints, understand subnational dynamics
  • Evaluation of Wolbachia supplier options and proposals for local context, e.g.,
    • Develop and apply supplier assessment framework across technical, operational, governance, and financing dimensions, conduct price comparison, and cost implications of different scale-up and delivery models
  • Development of Theory of Change and Wolbachia scale-up vision in Indonesia, e.g.,
    • Identify different strategic approaches for scale-up, create decision roadmap and timeline for national implementation
  • Conduct thorough desk reviews of existing dengue strategy, toolbox, reports, and guidelines related to dengue epidemiology and control.
  • Collaborate with government agencies and institutes to gather the data and conduct the assessment, including through interviews
  • Collect, organize, and analyze data from multiple sources, including government records, WHO-recommended dengue tools, and health information systems.
  • Collaborate with other CHAI technical teams and leadership to conduct analyses
  • Develop final deliverable (in the form of a presentation slide deck) to convey compelling storyline and clear recommendations, with impactful analyses and visual aids (e.g., graphs, flowcharts, tables, timelines, and maps)

Qualifications

• Bachelor’s degree plus 5 years of work experience
• Exceptional problem-solving skills and quantitative and qualitative analytical capabilities
• Exceptional English communication skills, including the ability to create compelling, structured, and clear oral and written communication style
• Ability to ramp up quickly on technical scientific and health topics, as Wolbachia is a vector control intervention with technical factors that influence operational considerations
• Ability to create strong visual communication materials in PowerPoint
• Ability to develop and apply quantitative models using Excel and other tools
• Excellent people skills and ability to navigate within the Ministry of Health
• Indonesian (Bahasa) language skills, including ability to communicate with stakeholders and read key documents

Advantages:

• Advanced degree in a health or business-related field
• Experience in working with dengue and/or other infectious diseases
• Experience in vector control or entomology
• In-depth knowledge of the Indonesian public health landscape

Application Submission

A one-page cover letter should specify the position sought and highlight why the candidate believes they are the right person for the position, including proposed methods for conducting relevant analyses and. A CV detailing professional experience, relevant qualifications and three reference contacts should be provided. Interested candidates should send materials to indonesiaoffice@clintonhealthaccess.org  with subject: Dengue Technical Advisor_Name. Applications will be reviewed as they arrive but must be received by 21 Feb 2026. Only shortlisted candidates will be invited for interview.